Prognostic value of microRNA-495-3p, adiponectin, and cardiometabolic index in type 2 diabetic nephropathy

doi:10.4239/wjd.v16.i7.108262

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (546)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

HTML

254

Figures (1-1)

Tables (1-6)

Sum=425

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=81

Jul 15, 2025 (publication date) through Aug 9, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Diabetes. Jul 15, 2025; 16(7): 108262
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.108262

Table 3 Comparison of serum microRNA-495-3p, adiponectin, and cardiometabolic index levels between the good prognosis group and the poor prognosis group, mean ± SD

Group	miR-495-3p	ADPN (μg/mL)	CMI
Good outcome (n = 61)	0.64 ± 0.11	11.98 ± 1.03	0.88 ± 0.10
Poor outcome (n = 37)	0.51 ± 0.16	13.78 ± 0.92	0.99 ± 0.14
t value	4.762	-8.724	-4.527
P value	< 0.001	< 0.001	< 0.001

miR-495-3p: microRNA-495-3p; ADPN: Adiponectin; CMI: Cardiometabolic index.

Citation: Xu XC, Fang HJ, Huang HY. Prognostic value of microRNA-495-3p, adiponectin, and cardiometabolic index in type 2 diabetic nephropathy. World J Diabetes 2025; 16(7): 108262
URL: https://www.wjgnet.com/1948-9358/full/v16/i7/108262.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i7.108262